Immatics Financial Statements From 2010 to 2025

IMTXW Stock  USD 0.05  0.01  39.60%   
Immatics Biotechnologies financial statements provide useful quarterly and yearly information to potential immatics biotechnologies GmbH investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Immatics Biotechnologies financial statements helps investors assess Immatics Biotechnologies' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Immatics Biotechnologies' valuation are summarized below:
Gross Profit
-62.2 M
Profit Margin
(1.04)
Market Capitalization
673 M
Revenue
70.9 M
Quarterly Revenue Growth
(0.16)
There are over one hundred nineteen available fundamental trends for Immatics Biotechnologies, which can be analyzed over time and compared to other ratios. All traders should should confirm Immatics Biotechnologies' regular fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable. Market Cap is likely to drop to about 480.3 M in 2025. Enterprise Value is likely to drop to about 373.5 M in 2025

Immatics Biotechnologies Total Revenue

57.76 Million

Check Immatics Biotechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immatics Biotechnologies' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 15.7 M or Interest Income of 16.7 M, as well as many indicators such as Price To Sales Ratio of 15.53, Dividend Yield of 0.0 or PTB Ratio of 3.22. Immatics financial statements analysis is a perfect complement when working with Immatics Biotechnologies Valuation or Volatility modules.
  
Check out the analysis of Immatics Biotechnologies Correlation against competitors.

Immatics Biotechnologies Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding70.8 M92.6 M65.8 M
Slightly volatile
Total Assets325.9 M586.5 M225.1 M
Slightly volatile
Short and Long Term Debt Total10.8 M17.7 M6.7 M
Slightly volatile
Other Current Liabilities25.2 M43.7 M13.4 M
Slightly volatile
Total Current Liabilities107.4 M180 M87.4 M
Slightly volatile
Property Plant And Equipment Net68.9 M65.6 M20.8 M
Slightly volatile
Current Deferred Revenue70.8 M115.5 M65.3 M
Slightly volatile
Accounts Payable4.9 M8.8 MM
Pretty Stable
Cash178.4 M251.2 M135.7 M
Slightly volatile
Non Current Assets Total73.2 M69.7 M23.4 M
Slightly volatile
Non Currrent Assets Other1.6 M2.3 M1.4 M
Slightly volatile
Cash And Short Term Investments282.6 M489.8 M195.7 M
Slightly volatile
Net Receivables6.9 M6.6 M3.3 M
Slightly volatile
Short Term Investments250.5 M238.5 M69.2 M
Slightly volatile
Liabilities And Stockholders Equity325.9 M586.5 M225.1 M
Slightly volatile
Non Current Liabilities Total102.9 M147.6 M104.4 M
Very volatile
Capital Lease Obligations10.8 M17.7 M6.7 M
Slightly volatile
Inventory0.860.9978.9 K
Slightly volatile
Other Current Assets21.4 M20.4 M5.5 M
Slightly volatile
Other Stockholder Equity623.1 M946.6 M382.5 M
Slightly volatile
Total Liabilities210.2 M327.6 M191.8 M
Slightly volatile
Property Plant And Equipment Gross96.5 M91.9 M34.4 M
Slightly volatile
Total Current Assets295.2 M516.8 M204.4 M
Slightly volatile
Capital Stock645.8 K762.3 K995 K
Slightly volatile
Non Current Liabilities Other3.4 K3.6 K1.3 M
Slightly volatile
Net Working Capital187.8 M336.7 M116.9 M
Slightly volatile
Intangible Assets1.4 M1.8 M1.2 M
Slightly volatile
Common Stock645.8 K762.3 K995 K
Slightly volatile

Immatics Biotechnologies Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income15.7 M15 M3.4 M
Slightly volatile
Interest Income16.7 M15.9 M4.2 M
Slightly volatile
Depreciation And Amortization5.6 M8.3 M3.9 M
Slightly volatile
Interest Expense907.9 K955.6 K831.4 K
Slightly volatile
Selling General Administrative29.7 M43.9 M18.5 M
Slightly volatile
Total Revenue57.8 M62.1 M29.1 M
Slightly volatile
Other Operating Expenses111.9 M179.1 M75.4 M
Slightly volatile
Research Development83.3 M136.5 M59.1 M
Slightly volatile
Total Operating Expenses111.9 M179.1 M75.4 M
Slightly volatile
Reconciled Depreciation5.5 M8.3 M3.8 M
Slightly volatile
Cost Of Revenue92.4 M136.5 M63.1 M
Slightly volatile

Immatics Biotechnologies Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation17.4 M23.8 M9.3 M
Slightly volatile
Begin Period Cash Flow117.4 M170.8 M62.2 M
Slightly volatile
Depreciation5.5 M8.3 M3.8 M
Slightly volatile
Capital Expenditures37.4 M35.6 M8.1 M
Slightly volatile
End Period Cash Flow155.9 M251.2 M98.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio15.5316.3487.4495
Slightly volatile
Days Sales Outstanding55.6231.82112
Slightly volatile
Stock Based Compensation To Revenue0.330.350.3914
Very volatile
Capex To Depreciation4.043.851.1571
Slightly volatile
EV To Sales11.4212.0279.8022
Slightly volatile
Inventory Turnover29.0123.3628.6233
Slightly volatile
Days Of Inventory On Hand0.00.01.8265
Pretty Stable
Payables Turnover15.1613.9312.9678
Slightly volatile
Sales General And Administrative To Revenue1.030.811.4851
Slightly volatile
Average Inventory907.8 K1.5 M948.8 K
Slightly volatile
Research And Ddevelopement To Revenue3.422.536.0439
Slightly volatile
Capex To Revenue0.540.520.2128
Slightly volatile
Cash Per Share2.744.762.1699
Slightly volatile
Days Payables Outstanding28.0927.1235.5953
Slightly volatile
Intangibles To Total Assets0.00330.00340.0116
Slightly volatile
Current Ratio2.12.582.3104
Slightly volatile
Receivables Turnover21.9211.8713.4233
Slightly volatile
Graham Number5.077.833.8639
Slightly volatile
Capex Per Share0.360.350.0963
Slightly volatile
Revenue Per Share0.640.60.4074
Slightly volatile
Interest Debt Per Share0.120.180.076
Slightly volatile
Debt To Assets0.02730.02720.0276
Slightly volatile
Short Term Coverage Ratios4.064.574.98
Slightly volatile
Operating Cycle60.9731.82115
Slightly volatile
Days Of Payables Outstanding28.0927.1235.5953
Slightly volatile
Ebt Per Ebit1.581.11.1787
Slightly volatile
Quick Ratio2.12.582.3059
Slightly volatile
Net Income Per E B T1.071.030.9766
Pretty Stable
Cash Ratio1.941.61.6153
Pretty Stable
Days Of Inventory Outstanding0.00.01.8265
Pretty Stable
Days Of Sales Outstanding55.6231.82112
Slightly volatile
Fixed Asset Turnover0.810.851.4893
Slightly volatile
Debt Ratio0.02730.02720.0276
Slightly volatile
Price Sales Ratio15.5316.3487.4495
Slightly volatile
Asset Turnover0.140.09530.1111
Slightly volatile

Immatics Biotechnologies Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap480.3 M690.6 M567.1 M
Slightly volatile
Enterprise Value373.5 M507.8 M479.3 M
Pretty Stable

Immatics Fundamental Market Drivers

Cash And Short Term Investments425.9 M

About Immatics Biotechnologies Financial Statements

Immatics Biotechnologies investors use historical fundamental indicators, such as Immatics Biotechnologies' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immatics Biotechnologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue115.5 M70.8 M
Total Revenue62.1 M57.8 M
Cost Of Revenue136.5 M92.4 M
Stock Based Compensation To Revenue 0.35  0.33 
Sales General And Administrative To Revenue 0.81  1.03 
Research And Ddevelopement To Revenue 2.53  3.42 
Capex To Revenue 0.52  0.54 
Revenue Per Share 0.60  0.64 
Ebit Per Revenue(1.70)(1.78)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immatics Stock Analysis

When running Immatics Biotechnologies' price analysis, check to measure Immatics Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics Biotechnologies is operating at the current time. Most of Immatics Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Immatics Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics Biotechnologies' price. Additionally, you may evaluate how the addition of Immatics Biotechnologies to your portfolios can decrease your overall portfolio volatility.